Skip to content

Evaluation of antioxidant effects of NAC and vitamin B6 in comparison with NAC and placebo, in chemical warfare victims Chronic pulmonary lesions

Evaluation of antioxidant effects of NAC and vitamin B6 in comparison with NAC and placebo, in chemical warfare victims Chronic pulmonary lesions

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20080901001165N54
Enrollment
56
Registered
2020-05-23
Start date
2019-11-11
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

war chemical gas pulmonary disease. Chronic respiratory conditions due to chemicals, gases, fumes and vapors

Interventions

Intervention 1: Intervention group: NAC effervescent tablets 600 mg, 3 times a day,and 50 mg of vitamin B6 tablets, PO, daily, for 6 weeks. Intervention 2: Control group: NAC effervescent tablets 60

Sponsors

Vice Chancellor for Research, Baqiyatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic lung lesions caused by war chemical gases have been proven; According to the patient's spirometry results, the pulmonary injury is not severe; The patient should have freely informed written consent to participate in the study.

Exclusion criteria

Exclusion criteria: Suffering from lung function-related diseases of lung origin, including asthma, bronchiectasis, etc. Suffering from lung function-related diseases of non-lung origin, including ALS, kyphosis, etc.

Design outcomes

Primary

MeasureTime frame
Spirometry parameters changes. Timepoint: Before intervention, then 6 weeks later. Method of measurement: Spirometer.

Secondary

MeasureTime frame
Quality of life. Timepoint: Before intervention, then 6 weeks later. Method of measurement: ACT Questionnaire.;Total antioxidant capacity. Timepoint: Before intervention, then 6 weeks later. Method of measurement: Total Antioxidant Capacity Assay Kit.;Malondialdehyde (MDA). Timepoint: before intervention, then 6 weeks later. Method of measurement: human Elisa kit.;Superoxide dismutase (SOD). Timepoint: before intervention, then 6 weeks later. Method of measurement: human Elisa kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadjavad Ershadi

Bagheiat-allah University of Medical Sciences

mjershad@gmail.com+98 21 8248 2503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026